¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium : 2022-05-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium : 2022-05-14
±³À°ÀÏÀÚ : 2022-05-14
±³À°Àå¼Ò : ¿Â¶óÀÎ °³ÃÖ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium 
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ Áغñ»ç¹«±¹
¿¬¶ôó : 02-373-1005  
À̸ÞÀÏ : kaslsecretariat@hbni.co.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í »çÀüµî·Ï-ȸ¿ø, ÀüÀÓÀÇ, Àü°øÀÇ 30,000¿ø / ºñȸ¿ø, ¿Â¶óÀΠȸ¿ø 40,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 10:10~10:35 Conventional and New Biomarkers for the Management of Chronic Hepatitis B Virus Infection  Marc G. Ghany(National Institute of Health, USA) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 10:35~11:00 Clinical Features of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Chronic Liver Disease  Ju Dong Yang(Cedars-Sinai Medical Center, USA) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:00~11:25 Novel Biomarkers for Renal Outcomes in Patients with Liver Cirrhosis  Jasmohan S. Bajaj(Virginia Commonwealth Univ., USA) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:25~11:50 Glycemic Control and Non-Alcoholic Fatty Liver Disease Prognosis  Manal F. Abdelmalek(Duke Univ. Medical Center, USA) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:00~13:20 Epidemiology and Natural History of Autoimmune Liver Diseases  Á¤¼÷Çâ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:20~13:40 Pathogenesis of Autoimmune Liver Diseases: Genetics and Environmental Factors  Áø¿µÁÖ(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:40~14:00 Autoimmune Liver Diseases after Viral Infections Including COVID-19 and Vaccines  ±è°æ¾Æ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:00~14:20 How Do Drugs Trigger Autoimmune Liver Injury?: Immune Checkpoint Inhibitors and Biological Agents  À¯¼öÁ¾(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:40~15:00 Diagnosis of Autoimmune Hepatitis and Overlap Syndrome  ¹ÚÁ¤±æ(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:00~15:20 Differential Pathologic Features between AIH, PBC and PSC  ÀÌÇý¿ø(°è¸íÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:20~15:40 Standard and Emerging Treatments of Autoimmune Liver Disease  ¹Ú¼ö¿µ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:40~16:00 Rescue Therapies for Relapsing and Difficult-To-Treat Autoimmune Liver Disease  ¼ÛÁ¤Àº(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 12:30~13:00 ÃÊÀ½ÆÄ ±â±â ¼¼Æà ¹æ¹ý  ±èż®(°­¿øÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:00~13:30 Á¤»ó °£ÃÊÀ½ÆÄ ½ºÄµ  ¼ºÇʼö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:30~14:00 Á¤»ó Ãé´ãµµ ÃÊÀ½ÆÄ ½ºÄµ  °­¹Î±Ô(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:00~14:30 °£Áúȯ ¹× Á¾±« ÃÊÀ½ÆÄ ½ºÄµ  ÀÌÀ¯¸²(°æºÏÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium : 2022-05-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѾ๰¿µ¾çÀÇÇÐȸ 2022³â Ãá°èÇмú´ëȸ : 2022-05-15
´ÙÀ½±Û ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ KSIN Spring symposium & Basic Training Course 2022 : 2022-05-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
270 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Á¦53Â÷ ¾Ë·¹¸£±â ±³À°°­Á : 2018-09-16 0 607 2018-07-28
269 ¼­¿ï 2018³â Á¦3ȸ »ï¼º¼­¿ïº´¿ø ¿Ü°ú ½ÉÆ÷Áö¿ò : 2018-09-16 0 951 2018-07-28
268 ´ë±¸ 2018³âµµ ´ëÇÑÁ¤Çü¿Ü°úÀÇ»çȸ Çмú´ëȸ : 2018-09-16 0 848 2018-07-28
267 ¼­¿ï ½ÉÀå´ë»çÁõÈıº¿¬±¸È¸ 2018 Ãß°è½ÉÆ÷Áö¾ö : 2018-09-15 0 692 2018-07-28
266 ¼­¿ï °æÈñ´ëÇб³º´¿ø µ¿¹®Áý´ãȸ_°íȲÀ̺ñÀÎÈÄ°ú ¿¬±¸È¸ ¼¼¹Ì³ª : 2018-09-15 0 1,445 2018-07-28
265 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : °æ°è¼± ÀΰÝÀå¾Ö : 2018-09-15 0 1,227 2018-07-28
264 ¼­¿ï ¼­¿ï¼º¸ðº´¿ø ½ÅÀåÀÌ½Ä 3,000·Ê ±â³ä ´ëÇÑÀ̽ÄÇÐȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2018-09-15 0 658 2018-07-28
263 °­¿ø ´ëÇÑ°ñÀýÇÐȸ Á¦2ȸ ÇÏÁö°ñÀý ½ÉÆ÷Áö¾ö : 2018-09-15 0 633 2018-07-28
262 Àü³² ¸ñÆ÷½ÃÀÇ»çȸ Çмú´ëȸ(°æµ¿¸Æ¼Õ»ó,°áÇÙ) : 2018-09-15 0 2,720 2018-07-28
261 ¼­¿ï °í·Á´ëÇб³ ½Å°æ°úÇб³½Ç ½ÉÆ÷Áö¿ò : 2018-09-15 0 1,972 2018-07-28
260 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÄÚºí·¹ÀÌÅ͸¦ ÀÌ¿ëÇÑ ´Ù¾çÇÑ ºñ°ú ¼ö¼úµé : 2018-09-15 0 773 2018-07-28
259 °æ±â Á¦6ȸ ÇѸ²´ëÇб³¼º½Éº´¿ø Á¤Çü¿Ü°ú °³¿øÀÇ ½ÉÆ÷Áö¿ò : 2018-09-15 0 904 2018-07-28
258 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª : 2018-09-14 0 655 2018-07-28
257 ¼­¿ï »ï¼º¼­¿ïº´¿ø 2018 »ï¼º ¾È°ú ±Ý¿äÁý´ãȸ : 2018-09-14 0 671 2018-07-28
256 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2018 ÀÇ·áÇöÀå¿¡¼­ ¸¸³ª´Â ¾à¹°¾Ë·¹¸£±â : 2018-09-14 0 832 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷